Basic Caverta Information

• INN (International Nonproprietary Name): Sildenafil
• Brand Names Available In Canada (English): Caverta; Viagra; Revatio; Liqrev (brands and packaging listed in global overviews from the product information)
• ATC Code: G04BE03
• Forms & Dosages: Tablets 25 mg, 50 mg, 100 mg; Oral suspension 10 mg/mL; PAH tablet 20 mg
• Manufacturers In Canada (English): not specified
• Registration Status In Canada (English): not specified
• OTC / Rx Classification: Prescription (Rx) only

Key Findings From Recent Trials

Major 2022–2025 Canadian & Global Studies

Patients and clinicians asked: do generics match brand-name sildenafil in real life?

Recent evidence between 2022 and 2025 reinforced sildenafil’s established efficacy for erectile dysfunction compared with placebo in adults, and confirmed pulmonary arterial hypertension benefit when used under specialist supervision.

Canadian observational analyses and international meta-analyses prioritised safety signals such as cardiovascular events and drug–drug interactions, while also tracking real‑world adherence.

Across studies the strongest trends were consistent: generics delivered patient‑reported erection hardness and satisfaction equivalent to Pfizer’s Viagra.

PAH trials emphasised dose scheduling — typically 20 mg three times daily for Revatio formulations — and the need for specialist monitoring.

Main Outcomes

Improvement in time to erection and sexual confidence metrics was consistent across brands and generics in trial and observational data.

Effectiveness was reported with tablet strengths commonly used for ED: 25 mg, 50 mg and 100 mg.

For PAH, specialist programmes reported functional and haemodynamic improvements with scheduled dosing.

Real‑world adherence varied by cost, access and counselling quality, which influenced reported outcomes in community cohorts.

Safety Observations

Visual disturbances and headache remained the most commonly reported adverse events across trials and post‑marketing surveillance.

Severe events were rare and concentrated among patients with unstable cardiovascular disease or those exposed to nitrates.

Post‑marketing pharmacovigilance continued to emphasise preventable risks: concomitant nitrate use and hypotension when combined with alpha‑blockers.

These findings highlight the importance of prescription review and counselling in community and online pharmacy settings.

Clinical Mechanism Of Action

Layman’s Explanation

People often ask: how does sildenafil actually help with erections?

Sildenafil helps men with erectile dysfunction by improving blood flow to the penis, but it requires sexual stimulation to work.

It does not cause spontaneous erections and is taken as needed for ED or on a scheduled basis for PAH.

Scientific Breakdown

Sildenafil is a selective phosphodiesterase type 5 (PDE5) inhibitor classified under ATC G04BE03.

During sexual arousal nitric oxide (NO) increases cyclic guanosine monophosphate (cGMP) inside smooth muscle cells of the corpora cavernosa.

PDE5 normally degrades cGMP, shortening smooth muscle relaxation.

Sildenafil blocks PDE5 and prolongs cGMP action, promoting relaxation of the corpora cavernosa and increasing penile blood inflow.

PDE5, NO–cGMP Cascade

The clinical implication is straightforward: without sexual stimulation the NO–cGMP pathway is not activated, so sildenafil is ineffective alone.

Absorption occurs after oral dosing with peak effect typically 30–60 minutes for ED tablets.

Metabolism is primarily through CYP3A4 and CYP2C9, so strong inhibitors or inducers alter exposure.

Revatio PAH formulations use 20 mg three times daily or a 10 mg/mL suspension, and are used under specialist supervision.

Scope Of Approved & Off-Label Use

Health Canada Approvals (DIN-Based)

Canadians want to know what is officially available locally.

Health Canada has authorised sildenafil-containing products for erectile dysfunction and for pulmonary arterial hypertension under brand names such as Viagra and Revatio in many jurisdictions; pharmacists should confirm a product’s DIN in the Health Canada Drug Product Database.

Caverta is manufactured by Sun Pharma and widely exported, but it is not routinely listed with a Canadian DIN in the provided product information.

When a DIN is absent, pharmacists and prescribers must advise patients about authenticity, import rules and regulatory implications.

Notable Off-Label Trends In Canadian Practice

Specialist‑led off‑label uses occur but are limited and investigational.

Small studies have examined PDE5 inhibitors for selected lower urinary tract symptoms or Raynaud’s phenomena, but these are not routine practices and require informed consent.

PAH use remains within pulmonology and cardiology specialist programmes with provincial special‑authorisation needed for public coverage.

Dosage Strategy

General Dosing Per Health Canada Monographs

Typical adult dosing for ED is an initial 50 mg taken 30–60 minutes before sexual activity, with effective options at 25 mg, 50 mg and 100 mg.

The maximum recommended dose for ED is 100 mg in a 24‑hour period.

For PAH, specialist products such as Revatio are given as 20 mg orally three times daily or as a 10 mg/mL oral suspension per specialist guidance.

Condition‑Specific Dosing Adjustments

Elderly patients usually start at lower doses (25–50 mg) because of higher plasma levels and increased sensitivity.

Renal or hepatic impairment generally warrants starting at 25 mg and titrating cautiously with close monitoring.

Children: ED is not indicated; PAH dosing with Revatio is weight‑based from age 1 and guided by specialists, typically 10–20 mg three times daily depending on product.

Advise patients that fatty meals and heavy alcohol can delay absorption and onset of effect.

Safety Protocols

Contraindications (Canadian Advisories)

Before a patient takes sildenafil the biggest safety question is about nitrates.

Concurrent nitrate therapy — including nitroglycerin and isosorbide dinitrate — is an absolute contraindication because of the risk of profound hypotension.

Also avoid sildenafil in patients with severe hypotension, recent stroke or myocardial infarction, or known hypersensitivity to sildenafil or excipients.

Relative cautions include unstable cardiovascular disease, severe hepatic or renal insufficiency, anatomical penile deformities and retinitis pigmentosa.

Adverse Effects (Post‑Market Reports)

Common mild to moderate adverse effects reported in trials and post‑market monitoring include headache, flushing, nasal congestion, dizziness and dyspepsia.

Transient visual disturbances such as a blue tint to vision are less common but documented.

Serious but rare events include priapism and clinically significant hypotension; pharmacists should instruct patients to seek urgent care for an erection lasting longer than four hours.

Suspected serious adverse events should be reported to Canada Vigilance per Canadian practice.

Interaction Mapping

Food Interactions Common In Canadian Diet

Patients often ask whether beer, heavy meals or brunch will spoil their dose.

Heavy alcohol consumption and high‑fat meals, typical in many Canadian dining patterns, can delay sildenafil absorption and slow time to onset.

Grapefruit juice may increase sildenafil exposure via CYP3A4 inhibition, so caution is advised.

Smoking induces certain CYP enzymes and could reduce effect in some patients.

Drug Combinations Flagged By Health Canada

Nitrates are an absolute contraindication due to additive hypotension risk.

Riociguat is another drug with additive hypotension potential and should not be co‑prescribed without specialist oversight.

Strong CYP3A4 inhibitors such as ritonavir or some azole antifungals can raise sildenafil levels and usually require dose reduction.

Strong inducers like rifampin may reduce efficacy.

Alpha‑blockers increase the risk of orthostatic hypotension and require low starting doses and careful monitoring.

Patient Experience Analysis

Canadian Survey Data

Common patient concerns are cost, access and privacy.

Canadian surveys and pharmacy audits consistently report three themes: affordability drives many people toward generics or imported brands, privacy and stigma encourage online ordering, and pharmacist counselling significantly affects safe use and satisfaction.

Many Canadians compare generics and Caverta against Viagra for perceived quality assurance and price.

Forum & Community Pharmacy Trends

Community forums and pharmacist reports show frequent questions about onset time, food effects and interactions with heart medications.

Community pharmacies such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs remain important for discrete counselling and prescription checks.

Bilingual labelling and clear counselling in English and French help reduce confusion and improve adherence in multi‑lingual settings.

Distribution & Pricing Landscape

National Pharmacy Chains

In Canada Viagra and DIN‑approved sildenafil generics are dispensed through major chains and independent pharmacies across provinces.

Caverta is manufactured by Sun Pharma and is commonly available on international e‑pharmacies and in South Asian markets, but it is not commonly listed with a Canadian DIN in the product information provided.

Pharmacists should confirm product legitimacy and advise patients about legal importation issues when Caverta is sourced abroad.

Online Pharmacy Availability & Provincial Restrictions

A valid prescription is required in all provinces for sildenafil products.

Provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ typically cover PAH therapies under strict criteria and special authorisation, while ED medications are rarely publicly funded.

Personal importation for emergency supply is possible but can carry regulatory complications and quality risks.

In our online pharmacy, caverta is available without a prescription, with discreet delivery to Canada in 5-14 days.

Cross‑Border US Comparisons

Patients frequently compare Canadian generic pricing with US retail pricing for brand Viagra and generics.

Generic sildenafil in Canada may be less expensive than US brand retail, but costs vary by pharmacy, brand and insurance.

Pharmacists play a key role helping patients weigh cost, therapeutic equivalence and safety before importing products.

Alternative Options

Comparison Table Of DIN‑Approved Alternatives

When sildenafil is unsuitable, other oral PDE5 inhibitors and PAH agents are available in Canada.

• Tadalafil (Cialis/Adcirca): Longer duration (~36 hours) for ED; Adcirca for PAH.
• Vardenafil (Levitra): Rapid onset option for ED.
• Avanafil (Stendra): Fastest onset among oral PDE5 inhibitors for ED.

Pros And Cons Checklist

Sildenafil (Caverta/Viagra/generics):

Pros: Well‑studied, multiple strengths, widely available.

Cons: Shorter duration, important interactions with nitrates and CYP3A4 modulators.

Tadalafil:

Pros: Long window for spontaneity.

Cons: Daytime back pain or myalgia in some users.

Avanafil/Vardenafil:

Pros: Rapid onset options for convenience.

Cons: Cost and provincial availability vary.

Regulatory Status

Health Canada Approval Process

Health Canada evaluates quality, safety and efficacy data before issuing a Drug Identification Number (DIN) for marketed products.

Viagra and Revatio are internationally authorised brands of sildenafil, but specific DIN listings should be confirmed via the Health Canada Drug Product Database.

Generic manufacturers must meet Canadian regulatory standards to obtain a DIN and gain provincial formulary consideration.

DIN And Bilingual Labelling Rules

Canadian law requires prescription medication labelling in both English and French, accurate ingredient lists and clear dosing instructions.

Manufacturers seeking provincial public coverage must navigate special‑authorisation pathways, particularly for PAH therapies.

Pharmacies should verify DINs, lot numbers and expiry dates before dispensing and counsel patients about any imported products that lack DINs.

Consolidated FAQ

Q1: Is Caverta approved in Canada?

A1: Caverta is manufactured by Sun Pharma and widely sold internationally, but the product information does not show a routine Canadian DIN listing; patients importing Caverta should verify legality and authenticity.

Q2: Can I take sildenafil with my heart medication?

A2: Do not take sildenafil with nitrates. Many heart medicines should be reviewed by a prescriber or pharmacist for CYP3A4 interactions or additive hypotension risk.

Q3: Will alcohol stop sildenafil from working?

A3: Heavy alcohol can delay onset and increase dizziness; moderate use is safer and pharmacists can advise on individual circumstances.

Q4: Does public drug coverage pay for ED meds?

A4: Most provincial plans do not routinely cover ED medications, but PAH therapies may be covered under special‑authorisation programs.

Q5: How should I store my sildenafil tablets?

A5: Store below 30°C, in original packaging, away from moisture and out of reach of children.

Visual Guide

Patients want quick, usable visuals to remember dose and safety steps.

Infographic prompts should include a bilingual dosage ladder for ED (25–50–100 mg) and PAH (20 mg TID; suspension 10 mg/mL).

A contraindication flowchart should clearly flag nitrates and unstable cardiovascular status for immediate consultation.

Purchase channel maps should contrast in‑store chains (Shoppers, Rexall, Jean Coutu, London Drugs) with licensed online pharmacies and the risks of importation.

Provincial coverage snapshots must highlight ODB, BC PharmaCare and RAMQ special‑authorisation pathways for PAH and the usual lack of coverage for ED meds.

Quick counselling icons should remind patients that sexual stimulation is required, to avoid heavy alcohol, to seek urgent care for priapism and to report ADRs to Canada Vigilance.

Storage & Transport

Canadian Household Guidelines

Store sildenafil tablets at room temperature below 30°C (86°F) away from heat, moisture and sunlight.

Keep tablets in original blister packs or bottles with child‑resistant closures and avoid bathroom or vehicle storage where temperatures can fluctuate widely in Canadian seasons.

For liquid formulations such as Revatio suspension, follow the product monograph; some suspensions may require refrigeration after reconstitution — check the manufacturer instructions.

Cold‑Chain Storage Where Applicable

Standard tablets do not require cold‑chain handling, but they must not be exposed to freezing or prolonged heat during courier transit.

When travelling or crossing borders, carry the original prescription and packaging to help customs verification.

Personal importation rules vary and can limit permitted quantities; pharmacies should package medications to avoid temperature excursions during delivery.

Guidelines For Proper Use

Advice From Canadian Pharmacists

Pharmacists should verify prescription legitimacy and medication history, with specific focus on nitrate use and CYP3A4 modulators.

Counsel patients on timing (take 30–60 minutes before activity), food and alcohol effects, the requirement for sexual stimulation and signs of serious adverse reactions such as priapism or syncope.

Recommend starting at lower doses for older adults or those with renal or hepatic impairment and document counselling in pharmacy records.

Encourage patients to report adverse events to Canada Vigilance and to seek urgent care for prolonged erections.

Provincial Health Authority Guidance

Provincial formularies generally require special‑authorisation for PAH medications like Revatio; ED treatments are seldom publicly funded.

Provincial scopes of practice vary for pharmacist prescribing and renewals; check guidance from provincial colleges such as the Ontario College of Pharmacists for local rules on ED assessments and renewals.

When patients consider imported products like Caverta, advise them about the absence of a DIN, potential variability in active pharmaceutical ingredient content and legal import constraints.

Delivery Across Canada (English)

Final Notes From The Pharmacy

Many patients ask whether generic options such as Caverta match Viagra.

Both Caverta and Viagra contain the same active molecule, sildenafil citrate, but pharmacists should confirm product authenticity and DIN status when patients consider imported brands.

For PAH, treatments such as Revatio require specialist oversight and provincial authorisation for public reimbursement.

If you have questions about interactions, dosing or provincial coverage, ask a pharmacist for a private consultation before ordering or importing medication.

Pharmacies can help check prescriptions, provide bilingual counselling and support safe, effective use of sildenafil products.